Krishna Bhupal lead investor of neuro42 now on Board

Medical technology company neuro42, Inc on Wednesday announced the appointment of its lead investor, Krishna Bhupal, to its Board of Directors. An entrepreneur and investor, Bhupal is involved in key industries such as energy, TAJGVK hospitality, health and real estate. His current investments are focused on the deep tech space including MedTech and include over 12 companies at various stages of maturity.

“We are excited to have Krishna Bhupal join the neuro42 team. His vast experience as a deep technology investor and as a business leader will enable us to navigate the ever-changing global landscape. As a team we look forward to his leadership as we drive awareness and market penetration as we scale our differentiated technology,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42.

On joining the Board Krishna said, “I am delighted to continue to be a part of neuro42’s journey to develop and market pioneering MR technologies for neurosurgical intervention which will change the economics of accessibility, availability and accessibility of healthcare. I look forward to the Company’s next phase of growth and for it to continue be a pioneer in the imaging and robotics space in America and move into the scale up phase.”